These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 36623239
1. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. Cheng HH, Sokolova AO, Gulati R, Bowen D, Knerr SA, Klemfuss N, Grivas P, Hsieh A, Lee JK, Schweizer MT, Yezefski T, Zhou A, Yu EY, Nelson PS, Montgomery B. JCO Precis Oncol; 2023 Jan; 7():e2200104. PubMed ID: 36623239 [Abstract] [Full Text] [Related]
2. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing. Giri VN, Hartman R, Pritzlaff M, Horton C, Keith SW. JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082 [Abstract] [Full Text] [Related]
4. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Isaacsson Velho P, Silberstein JL, Markowski MC, Luo J, Lotan TL, Isaacs WB, Antonarakis ES. Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341 [Abstract] [Full Text] [Related]
5. Commentary on: "Inherited DNA-repair gene mutations in men with metastatic prostate cancer." Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016 Aug 4;375(5):443-53. Lee BH. Urol Oncol; 2017 Sep; 35(9):575-576. PubMed ID: 28789927 [Abstract] [Full Text] [Related]
7. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. Truong H, Breen K, Nandakumar S, Sjoberg DD, Kemel Y, Mehta N, Lenis AT, Reisz PA, Carruthers J, Benfante N, Joseph V, Khurram A, Gopalan A, Fine SW, Reuter VE, Vickers AJ, Birsoy O, Liu Y, Walsh M, Latham A, Mandelker D, Stadler ZK, Pietzak E, Ehdaie B, Touijer KA, Laudone VP, Slovin SF, Autio KA, Danila DC, Rathkopf DE, Eastham JA, Chen Y, Morris MJ, Offit K, Solit DB, Scher HI, Abida W, Robson ME, Carlo MI. Eur Urol; 2023 Jan; 83(1):29-38. PubMed ID: 36115772 [Abstract] [Full Text] [Related]
9. Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer. Scheinberg T, Goodwin A, Ip E, Linton A, Mak B, Smith DP, Stockler MR, Strach MC, Tran B, Young AL, Zhang AY, Mahon KL, Horvath LG. JCO Oncol Pract; 2021 Feb; 17(2):e204-e216. PubMed ID: 32970524 [Abstract] [Full Text] [Related]
15. Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer. Chávarri-Guerra Y, Bourlon MT, Rodríguez-Olivares JL, Orozco L, Bazua D, Rodríguez-Faure A, Alcalde-Castro MJ, Castro E, Castillo D, Herzog J, Weitzel J. Clin Genitourin Cancer; 2023 Oct; 21(5):569-573. PubMed ID: 37380563 [Abstract] [Full Text] [Related]
16. DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries. Abdi B, Basset N, Perrot E, Benderra MA, Khalil A, Oudard S, Blanchet P, Brureau L, Coulet F, Cussenot O, Cancel-Tassin G. Prostate; 2022 Sep; 82(12):1196-1201. PubMed ID: 35652560 [Abstract] [Full Text] [Related]
17. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. Vlaming M, Bleiker EMA, van Oort IM, Kiemeney LALM, Ausems MGEM. BMC Cancer; 2022 Dec 30; 22(1):1365. PubMed ID: 36581909 [Abstract] [Full Text] [Related]
18. Genetic testing for hereditary prostate cancer: Current status and limitations. Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B. Cancer; 2018 Aug 01; 124(15):3105-3117. PubMed ID: 29669169 [Abstract] [Full Text] [Related]
19. Germline genetic variants in men with prostate cancer and one or more additional cancers. Pilié PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, Cooney KA. Cancer; 2017 Oct 15; 123(20):3925-3932. PubMed ID: 28657667 [Abstract] [Full Text] [Related]
20. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Ledet EM, Burgess EF, Sokolova AO, Jaeger EB, Hatton W, Moses M, Miller P, Cotogno P, Layton J, Barata P, Lewis BE, Nakazawa M, Zhu J, Dellinger B, Elrefai S, Nafissi NN, Egan JB, Shore N, McKay RR, Bryce AH, Cheng HH, Antonarakis ES, Sartor O. Prostate; 2021 May 15; 81(7):433-439. PubMed ID: 33792945 [Abstract] [Full Text] [Related] Page: [Next] [New Search]